» Articles » PMID: 37113730

Primary Neuroendocrine Breast Cancer-an Unusual Occurrence

Overview
Specialty Oncology
Date 2023 Apr 28
PMID 37113730
Authors
Affiliations
Soon will be listed here.
Abstract

Primary breast neuroendocrine neoplasms (BNENs) are a rare form of breast cancer, accounting for less than 0.1% of all breast malignancies. These neoplasms have a similar clinical presentation as conventional breast carcinomas, differing mainly in their histopathology and expression of neuroendocrine (NE) markers, chromogranin and synaptophysin. Owing to their rarity, current knowledge of these tumours comes mainly from corroborative case reports or retrospective case series. There is hence a lack of randomised data on the treatment of these entities and current protocol suggests similar treatment as that of conventional breast carcinomas. We report the case of a 48-year-old with a breast mass, which on further work-up was diagnosed as locally advanced carcinoma breast, that required a mastectomy and axillary node dissection on the same side and revealed NE differentiation on histopathological examination. Hence, immunohistochemical staining was indicated which confirmed NE differentiation. We discuss the current knowledge on incidence, demographics, diagnosis, histopathological and staining characteristics, prognostic factors and treatment modalities of BNENs.

Citing Articles

Neuroendocrine neoplasms of the breast: a review of literature.

Vegni F, De Stefano I, Policardo F, Tralongo P, Feraco A, Carlino A Virchows Arch. 2024; 485(2):197-212.

PMID: 38980337 PMC: 11329594. DOI: 10.1007/s00428-024-03856-y.

References
1.
Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A . Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives. Oncologist. 2015; 21(1):28-32. PMC: 4709213. DOI: 10.1634/theoncologist.2015-0309. View

2.
Savelli G, Zaniboni A, Bertagna F, Bosio G, Nisa L, Rodella C . Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation. Breast Care (Basel). 2014; 7(5):408-10. PMC: 3518936. DOI: 10.1159/000343612. View

3.
Patel G, Bipte S . Updates in primary neuroendocrine breast carcinoma - A case report and review of literature. J Cancer Res Ther. 2020; 16(6):1528-1531. DOI: 10.4103/jcrt.JCRT_176_19. View

4.
Bongiovanni A, Recine F, Foca F, Fausti V, Riva N, Fabbri G . Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age. Endocr Connect. 2018; 7(12):1535-1541. PMC: 6311458. DOI: 10.1530/EC-18-0478. View

5.
Park Y, Wu Y, Wei W, Yang W . Primary neuroendocrine carcinoma of the breast: clinical, imaging, and histologic features. AJR Am J Roentgenol. 2014; 203(2):W221-30. DOI: 10.2214/AJR.13.10749. View